| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.24B | 55.31B | 51.96B | 49.89B | 44.76B | 37.61B |
| Gross Profit | 9.57B | 9.46B | 8.98B | 9.04B | 8.22B | 6.72B |
| EBITDA | 1.10B | 1.22B | 1.02B | 1.13B | 646.00M | 16.18M |
| Net Income | 2.85B | 2.99B | 810.00M | 905.00M | 723.00M | 109.56M |
Balance Sheet | ||||||
| Total Assets | 32.31B | 32.76B | 29.54B | 29.09B | 25.51B | 23.00B |
| Cash, Cash Equivalents and Short-Term Investments | 9.60B | 9.08B | 6.31B | 6.23B | 5.17B | 5.14B |
| Total Debt | 1.16B | 250.00M | 272.00M | 325.00M | 588.00M | 862.13M |
| Total Liabilities | 17.94B | 18.20B | 16.23B | 16.15B | 14.32B | 13.08B |
| Stockholders Equity | 14.37B | 14.55B | 13.30B | 12.93B | 11.19B | 9.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.00B | 563.00M | 1.40B | 415.00M | 1.11B |
| Operating Cash Flow | 0.00 | 2.05B | 684.00M | 1.47B | 437.00M | 1.24B |
| Investing Cash Flow | 0.00 | 890.00M | -332.00M | -86.00M | -137.00M | -138.44M |
| Financing Cash Flow | 0.00 | -383.00M | -277.00M | -336.00M | -281.00M | 558.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥9.20B | 16.36 | ― | 3.96% | 7.77% | 247.26% | |
75 Outperform | ¥4.11B | 8.35 | ― | 4.78% | -11.24% | -48.52% | |
63 Neutral | ¥1.41T | 42.60 | 5.92% | 1.93% | 7.64% | 22.13% | |
62 Neutral | ¥282.14B | 21.92 | 15.93% | 0.72% | 20.06% | 17.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥27.71B | 14.57 | ― | 1.85% | 4.17% | -20.08% | |
61 Neutral | ¥46.82B | 11.29 | ― | 3.94% | 0.74% | 41.25% |